Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-24 @ 4:08 PM
NCT ID:
NCT02341066
Eligibility Criteria:
Inclusion Criteria:
* RA as defined by American College of Rheumatology/European League Against Rheumatisms 2010 RA classification criteria
* In the opinion of investigators, patients must be able to adhere to the study visit schedule and must be capable of giving informed consent
Exclusion Criteria:
* Previous cardiovascular or cerebrovascular events (acute coronary syndrome, stable angina, stroke, interventional procedures, carotid endarterectomy, symptomatic peripheral artery ischemia)
* Pathological ECG at rest
* Sign or symptoms of autonomous nervous system dysfunction
* Serious infections in the previous 6 months
* Concomitant severe illness: overt hepatic insufficiency; End stage renal disease (Glomerular Filtration Rate \<30 ml/h at Cockrofts-Gault formula); recent diagnosis of cancer
* Pregnancy
* Plans to leave target areas of each study site within three years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
84 Years
Study:
NCT02341066
Study Brief:
Protocol Section:
NCT02341066